Sandimmune Uses
Links shared publicly online about this topic
FDA Requires Labeling Change for Some Drugs Used to Prevent Rejection of Kidney Transplants
fda.gov — “The U.S. Food and Drug Administration today said that it will require manufacturers of some immunosuppressant drugs used in kidney (renal) transplantation to update their labeling to reflect an increased risk of infections.” View full resource at fda.gov
Most Recently Shared on July 14, 2009 at 4:05 pm By:
eyeonfda Pharma and Health Lawyer
FDA Requires Labeling Change for Some Drugs Used to Prevent Rejection of Kidney Transplants http://bit.ly/40cOo
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
eyeonfda
Author of the blog Eye on FDA - www.eyeonfda.com
Advertisement
